Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that prominent Seattle-based plastic surgeon Richard A. Baxter, M.D., FACS was recognized by Outpatient Surgery magazine for his use of EXPAREL ® (bupivacaine liposome injectable suspension) for postsurgical pain management. The award for “Best Use of Opioid Alternatives” will be presented during the OR Excellence Conference in Fort Lauderdale, Fla. from October 17 to 19.
An early adopter of EXPAREL, Dr. Baxter has been using the non-opioid local analgesic for several months to control postsurgical pain in patients undergoing abdominoplasty and breast augmentation procedures, which he says has reduced his opioid use by at least 50 percent.
“It has always been important to me to stay on the cutting edge of any advances that can help improve my patients’ postsurgical experience and control their discomfort during the healing process,” said Dr. Baxter, owner and medical director of Richard A. Baxter Plastic Surgery Clinic. “As we know, opioids are effective analgesics, but their associated side effects can pose multiple issues during the recovery process. I have used EXPAREL in more than 35 cases to date and my patients are in remarkably less discomfort, taking fewer opioids and are comfortable enough to begin to ambulate much sooner than we have previously seen.”
Also at the OR Excellence conference, Eugene R. Viscusi, M.D., anesthesiologist and director of acute pain management at Thomas Jefferson University in Philadelphia, will speak on emerging options in non-opioid analgesia in a CME presentation.“As an anesthesiologist and pain specialist, I recognize that pain management begins both before and during the anesthetic - not just after the operation,” said Dr. Viscusi. “Although they can be effective analgesics, opioids have problematic side effects. I always try to minimize reliance on opioids with a foundation of non-opioid analgesics such as local anesthetics, like EXPAREL; acetaminophen; and non-steroidal anti-inflammatory agents.”
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV